awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41807279-78778CB4-55E7-4D20-92AF-CD421F1582F5
Q41807279-78778CB4-55E7-4D20-92AF-CD421F1582F5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41807279-78778CB4-55E7-4D20-92AF-CD421F1582F5
Selective JAK2/ABL dual inhibition therapy effectively eliminates TKI-insensitive CML stem/progenitor cells.
P2860
Q41807279-78778CB4-55E7-4D20-92AF-CD421F1582F5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41807279-78778CB4-55E7-4D20-92AF-CD421F1582F5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dd891f69f57094da8d290210d49f12fc67164e3e
P2860
Loss of major molecular response as a trigger for restarting tyrosine kinase inhibitor therapy in patients with chronic-phase chronic myelogenous leukemia who have stopped imatinib after durable undetectable disease.